Bicyclol is under investigation in clinical trial NCT02944552 (The Multi Center, Randomized, Double-blind, Positive Controlled Study of Bicyclol in the Treatment of Acute DILI). Bicyclol has been reported in Aspergillus flavus and Isatis tinctoria with data available. BICYCLOL is a small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include 6-methoxycarbonyl-6′-hydroxymethyl-2, 3, 2′, 3′-bis(methylenedioxy)-4 and 4′-dimethoxybiphenyl. Its PubChem CID is 9821754.
Bicyclol
| CAS No | 118159-48-1 |
|---|---|
| Molecular Formula | C19H18O9 |
| Molecular Weight | 390.3 g/mol |
| Synonyms | methyl 4-[5-(hydroxymethyl)-7-methoxy-1,3-benzodioxol-4-yl]-7-methoxy-1,3-benzodioxole-5-carboxylate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Bicyclol is under investigation in clinical trial NCT02944552 (The Multi Center, Randomized, Double-blind, Positive Controlled Study of Bicyclol in the Treatment of Acute DILI).
The listed CAS number is 118159-48-1.
The listed molecular formula is C19H18O9.
The listed molecular weight is 390.3 g/mol.
methyl 4-[5-(hydroxymethyl)-7-methoxy-1,3-benzodioxol-4-yl]-7-methoxy-1,3-benzodioxole-5-carboxylate.
The source lists 6-methoxycarbonyl-6'-hydroxymethyl-2, 3, 2', 3'-bis(methylenedioxy)-4 and 4'-dimethoxybiphenyl.